Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 1/20 | 0.42 |
| ▸ | KDM4B | O94953 | 1/20 | 0.40 |
| ▸ | KDM5C | P41229 | 1/20 | 0.40 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 3/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.39 |
| ▸ | C1S | P09871 | 1/20 | 0.39 |
| ▸ | PLG | P00747 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | F10 | P00742 | 2/20 | 0.38 |
| ▸ | F7 | P08709 | 2/20 | 0.38 |
| ▸ | F12 | P00748 | 1/20 | 0.38 |
| ▸ | F3 | P13726 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9792756 | 0.83 | PRSS1 (0.50) | KDM4BKDM5CKDM5BF2PRSS1 | |
| SCHEMBL9792777 | 0.76 | PRSS1 (0.61) | F2PRSS1PRSS2PRSS3C1S | |
| SCHEMBL4951283 | 0.76 | PRSS1 (0.39) | KDM5CF2PRSS1PRSS2PRSS3 | |
| SCHEMBL4356178 | 0.74 | NQO2 (0.46) | NQO2F2PRSS1PRSS2PRSS3 | |
| SCHEMBL3504631 | 0.74 | PRSS1 (0.38) | KDM4BKDM5CKDM5BF2PRSS1 | |
| SCHEMBL14507287 | 0.73 | NQO2 (0.47) | NQO2F2PRSS1PRSS3 | |
| SCHEMBL28809489 | 0.71 | F2 (0.42) | F2PRSS1PRSS2PRSS3C1S | |
| SCHEMBL1159737 | 0.71 | F12 (0.44) | F2PRSS1PRSS2PRSS3C1S | |
| SCHEMBL8096354 | 0.70 | NQO2 (0.68) | NQO2F2PRSS1PRSS2PRSS3 | |
| SCHEMBL3788282 | 0.70 | NQO2 (0.49) | NQO2F2PRSS1PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7517893-B2 | Bichalcophenes and their prodrugs as antiprotozoal agents | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2009-04-14 | — | — | US | claimed |
| EP-1726589-B1 | 5,5'-bis-(4-amidinophenyl)-2,2'-bifuran derivatives and related compounds as antiprotozoal agent and prodrugs thereof | UNIV NORTH CAROLINA (US) | 2008-10-15 | — | — | EP | claimed |
| US-20060293540-A1 | Novel bichalcophenes and their prodrugs as antiprotozoal agents | TIDWELL RICHARD R | 2006-12-28 | — | — | US | claimed |
| EP-1726589-A2 | 5,5'-bis-(4-amidinophenyl)-2,2'-bifuran derivatives and related compounds as antiprotozoal agent and prodrugs thereof | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2006-11-29 | — | — | EP | claimed |
| US-20100249175-A1 | Dicationic compounds which selectively recognize G-quadruplex DNA | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2010-09-30 | — | — | US | disclosed |
| US-7517893-B2 | Bichalcophenes and their prodrugs as antiprotozoal agents | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2009-04-14 | — | — | US | disclosed |
| EP-1726589-B1 | 5,5'-bis-(4-amidinophenyl)-2,2'-bifuran derivatives and related compounds as antiprotozoal agent and prodrugs thereof | UNIV NORTH CAROLINA (US) | 2008-10-15 | — | — | EP | disclosed |
| EP-1792613-A2 | Dicationic compounds which selectively recognize G-quadruplex DNA | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2007-06-06 | — | — | EP | disclosed |
| US-20060293540-A1 | Novel bichalcophenes and their prodrugs as antiprotozoal agents | TIDWELL RICHARD R | 2006-12-28 | — | — | US | disclosed |
| EP-1726589-A2 | 5,5'-bis-(4-amidinophenyl)-2,2'-bifuran derivatives and related compounds as antiprotozoal agent and prodrugs thereof | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2006-11-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249175-A1 | Dicationic compounds which selectively recognize G-quadruplex DNA | DDB1, DNA2, SSBP1 | NQO2 1541/4885KDM4B 1701/4885KDM5C 2487/4885 |
| US-20060293540-A1 | Novel bichalcophenes and their prodrugs as antiprotozoal agents | CASP7, DDT, BAD | NQO2 1951/4885KDM4B 1945/4885KDM5C 2093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.